Alzheimer's Disease (AD) Clinical Trials

Inherited Diseases, Caregiving, and Social Networks

Conditions:   Alzheimer's Disease;   Inborn Errors of Metabolism;   Mitochondrial Disorders;   Undiagnosed Diseases
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified June 29, 2017

Learn More

Effect of CT1812 Treatment on Brain Synaptic Density

Condition:   Alzheimer Disease
Interventions:   Drug: Active Treatment- CT1812 100 mg;   Drug: Placebo;   Drug: Active Treatment- CT1812 300 mg
Sponsor:   Cognition Therapeutics

Learn More

An Open-Label Crenezumab Study in Patients With Alzheimer's Disease

Condition:   Alzheimer's Disease
Intervention:   Drug: Crenezumab (RO5490245)
Sponsor:   Hoffmann-La Roche

Learn More

46-48 of 48
Results per page

Join the community!

You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.